HELP     Sign In
Search

Relevance to Autism

Three de novo missense variants in the GABRB2 gene, including one that was predicted to be damaging (defined as MPC 2), were identified in ASD probands from the Simons Simplex Collection and the Autism Sequencing Consortium (Iossifov et al., 2014; Satterstrom et al., 2020), while two protein-truncating variants in this gene were observed in case samples from the Danish iPSYCH study (Satterstrom et al., 2020). TADA analysis of de novo variants from the Simons Simplex Collection and the Autism Sequencing Consortium and protein-truncating variants from iPSYCH in Satterstrom et al., 2020 identified GABRB2 as a candidate gene with a false discovery rate (FDR) between 0.05 and 0.1 (0.05 < FDR 0.1).

Molecular Function

The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. This gene encodes GABA A receptor, beta 2 subunit. Heterozygous mutations in this gene are responsible for infantile or early childhood epileptic encephalopathy-2 (IECEE2; OMIM 617829), a neurodevelopmental disorder characterized in most patients by onset of seizures in infancy or childhood and associated with global developmental delay and variable intellectual disability.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
The contribution of de novo coding mutations to autism spectrum disorder
ASD
Support
DD, ID, epilepsy/seizures
Support
Integrating de novo and inherited variants in 42
ASD
Support
Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder
ASD
Support
DD, ID
Recent recommendation
Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism
ASD

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN1166R001 
 missense_variant 
 c.50T>C 
 p.Leu17Ser 
 De novo 
  
 Simplex 
 GEN1166R002 
 missense_variant 
 c.946G>A 
 p.Val316Ile 
 De novo 
  
 Simplex 
 GEN1166R003 
 missense_variant 
 c.1088A>C 
 p.His363Pro 
 De novo 
  
 Simplex 
 GEN1166R004 
 stop_gained 
 c.573C>G 
 p.Tyr191Ter 
 Unknown 
  
  
 GEN1166R005 
 splice_region_variant 
 c.541+7C>T 
  
 De novo 
  
  
 GEN1166R006 
 missense_variant 
 c.895A>C 
 p.Ile299Leu 
 De novo 
  
  
  et al.  
 GEN1166R007 
 missense_variant 
 c.869C>T 
 p.Thr290Ile 
 Familial 
 Maternal 
  
  et al.  

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
5
Duplication
 1
 
5
Duplication
 1
 
5
Deletion
 1
 
5
Deletion
 1
 
5
Duplication
 1
 

Model Summary

The GABRB2 KO mice, and HT mice to a lesser extent, display prepulse inhibition (PPI) deficit, locomotor hyperactivity, stereotypy, sociability impairments, spatial-working and spatial-reference memory deficits, reduced depression and anxiety, accelerated pentylenetetrazol (PTZ)-induced seizure, increased susceptibility to audiogenic epilepsy, GABAergic parvalbumin (PV)-positive interneuron dystrophy, astrocyte dystrophy, inreased microglia activation in the frontotemporal corticolimbic regions, decreased newborn neurons in the hippocampus, increased brain levels of oxidative stress and the pro-inflammatory cytokines TNFa and IL6. Risperidone and diazepam ameliorated some phenotypes in GABRB2 KO mice.

References

Type
Title
Author, Year
Primary
Gabrb2-knockout Mice Displayed Schizophrenia-Like and Comorbid Phenotypes With Interneuron-Astrocyte-Microglia Dysregulation

M_GABRB2_1_KO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Mice with genomic deletion of exon7 of Gabrb2 were generated by crossing mice where a genomic fragment containing exon 7 was replaced with a loxP flanked neomycin selection cassette and CMV-Cre mice that expresses Cre recombinase transgene under the control of a human cytomegalovirus (CMV) promoter, active in most cells and tissues.
Allele Type: Knockout
Strain of Origin: 129S7/SvEvBrd-Hprt^b-m2
Genetic Background: C57BL/6*129*SvEvhybrid
ES Cell Line: Not specified
Mutant ES Cell Line: Not specified
Model Source: Taconic Farms, Inc., New York; Sur C et al, J Neurosci, 2001

M_GABRB2_2_KO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Mice with genomic deletion of exon7 of Gabrb2 were generated by crossing mice where a genomic fragment containing exon 7 was replaced with a loxP flanked neomycin selection cassette and CMV-Cre mice that expresses Cre recombinase transgene under the control of a human cytomegalovirus (CMV) promoter, active in most cells and tissues.
Allele Type: Knockout
Strain of Origin: 129S7/SvEvBrd-Hprt^b-m2
Genetic Background: C57BL/6*129*SvEvhybrid
ES Cell Line: Not specified
Mutant ES Cell Line: Not specified
Model Source: Taconic Farms, Inc., New York; Sur C et al, J Neurosci, 2001

M_GABRB2_3_KO_HT-M-P+

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Mice with genomic deletion of exon7 of Gabrb2 were generated by crossing mice where a genomic fragment containing exon 7 was replaced with a loxP flanked neomycin selection cassette and CMV-Cre mice that expresses Cre recombinase transgene under the control of a human cytomegalovirus (CMV) promoter, active in most cells and tissues. To examine effects of parent-of-origin, paternal het (HT-P) mice were generated by mating WT male with KO female such that a normal copy of Gabrb2 was acquired from the father in HT-P mice.
Allele Type: Knockout
Strain of Origin: 129S7/SvEvBrd-Hprt^b-m2
Genetic Background: C57BL/6*129*SvEvhybrid
ES Cell Line: Not specified
Mutant ES Cell Line: Not specified
Model Source: Taconic Farms, Inc., New York; Sur C et al, J Neurosci, 2001

M_GABRB2_4_KO_HT-M+P-

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Mice with genomic deletion of exon7 of Gabrb2 were generated by crossing mice where a genomic fragment containing exon 7 was replaced with a loxP flanked neomycin selection cassette and CMV-Cre mice that expresses Cre recombinase transgene under the control of a human cytomegalovirus (CMV) promoter, active in most cells and tissues. To examine effects of parent-of-origin, maternal het (HT-M) mice were generated by mating KO male with WT female, such that a normal copy of Gabrb2 was acquired from the mother in HT-M mice.
Allele Type: Knockout
Strain of Origin: 129S7/SvEvBrd-Hprt^b-m2
Genetic Background: C57BL/6*129*SvEvhybrid
ES Cell Line: Not specified
Mutant ES Cell Line: Not specified
Model Source: Taconic Farms, Inc., New York; Sur C et al, J Neurosci, 2001

M_GABRB2_1_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity1
Increased
Description: Mutants show increased locomotor activity in the zil-2 apparatus, compared with controls.
Exp Paradigm: NA
 Novel cage test
 8-10 weeks
Neuroreceptor levels: gaba-r: gabaa1
Abnormal
Description: Mutants show upregulation for gabrd, but downregulations for gabra1, gabra2, gabra5 and gabra6 in the cerebellum.
Exp Paradigm: Gaba-a
 Quantitative pcr (qrt-pcr)
 10-11 weeks
Neuronal number: interneurons1
Decreased
Description: Mutants show decrease in the number of parvalbumin positive interneurons in the anterior cingulate and piriform cortices but no change in the number of parvalbumin positive neurons in the dentate gyrus or the hippocampus or the central amygdaloid nucleus.
Exp Paradigm: Pv
 Immunohistochemistry
 10-11 weeks
Glial number1
Decreased
Description: Mutants show decrease in the number of gfap positive astrocytes in the ca1 hippocampus and the dentate gyrus but not in the acc.
Exp Paradigm: Gfap
 Immunohistochemistry
 10-11 weeks
Neuroreceptor levels: gaba-r: gabaa1
Abnormal
Description: Mutants show upregulation of gabrb1, gabrg1, and gabrg2 and down-regulation of downregulations for gabra1, gabra2, and gabra5 in the ko cerebrum.
Exp Paradigm: Gaba-a
 Quantitative pcr (qrt-pcr)
 10-11 weeks
Cell proliferation: neural precursors1
Decreased
Description: Mutants show fewer dcx positive neural precursors in the dentate gyrus and ca1 hippocampus.
Exp Paradigm: Dcx
 Immunohistochemistry
 10-11 weeks
Oxidative stress in neurons1
Increased
Description: Mutants show increased levels of malondialdehyde in the brain but no elevation of oxidative markers in the blood or liver.
Exp Paradigm: NA
 Measurement of enzyme activity
 10-11 weeks
Stereotypy: climbing1
Increased
Description: Mutants show increased climbing compared with controls.
Exp Paradigm: NA
 Novel cage test
 8-10 weeks
Seizures1
Increased
Description: Mutants show increased susceptibility and decreased latency for ptz induced seizures compared with controls. the average latency to seizure was shorter for female than for male.
Exp Paradigm: NA
 Observation of chemically induced seizures
 3 weeks, 10 weeks
Seizures1
Increased
Description: Mutants show increased audiogenic seizures characterized by wild running followed by tonic seizure compared with controls. the average latency to seizure was shorter for female ko than for male ko at both week-3 and week-10.
Exp Paradigm: NA
 Audiogenic seizure test
 3 weeks, 10 weeks
Sensorimotor gating1
Decreased
Description: Mutants show decreased ppi compared with controls at 77110, 77120, and 83110 db prepulse-pulse combinations but not at 83120 db combinations.
Exp Paradigm: NA
 Prepulse inhibition
 8-10 weeks
Startle response: acoustic stimulus1
Increased
Description: Mutants show increased startle amplitude at 100, 110, and 120 db sounds compared with controls.
Exp Paradigm: NA
 Acoustic startle reflex test
 8-10 weeks
Social memory1
Decreased
Description: Mutants show decrease in time spent and number of contacts with an unfamiliar mouse over a familiar mouse compared with controls.
Exp Paradigm: NA
 Three-chamber social approach test
 9-10 weeks
Social approach1
Decreased
Description: Mutants show decrease in time spent and number of contacts with an unfamiliar mouse over an empty cup compared with controls.
Exp Paradigm: NA
 Three-chamber social approach test
 9-10 weeks
Rearing behavior1
Increased
Description: Mutants show increased rearing compared with controls.
Exp Paradigm: NA
 Novel cage test
 8-10 weeks
Reproductive function1
Decreased
Description: Mutants show small litter sizes when both parents were nave ko mutants compared to litter sizes when nave male ko mice were mated with nave female ht or wt or when wt pairs were mated.
Exp Paradigm: NA
 Litter size
 8 weeks
Depression1
Decreased
Description: Mutants show increase in sucrose preference compared to wildtype controls.
Exp Paradigm: NA
 Sucrose preference test
 8-10 weeks
Anxiety1
Decreased
Description: Mutants show increase in the number of entries into the open arms compared to controls.
Exp Paradigm: NA
 Elevated plus maze test
 8-10 weeks
Depression1
Decreased
Description: Mutants spent less time immobile compared to wildtype controls.
Exp Paradigm: NA
 Tail suspension test
 8-10 weeks
Cytokine levels: pro-inflammatory1
Increased
Description: Mutants show increased levels of tnfalpha and il-6 in the brain.
Exp Paradigm: NA
 Elisa
 10-11 weeks
Cns inflammation1
Increased
Description: Mutants show increase in the number of iba1 positive microglia in the ca1, dg, acc, cea, and pc but not in the pmc.
Exp Paradigm: NA
 Immunohistochemistry
 10-11 weeks
Spatial reference memory1
Decreased
Description: Mutants show reduced target-quadrant visitation time and entries compared with controls.
Exp Paradigm: NA
 Morris water maze test
 8-10 weeks
Spatial working memory1
Decreased
Description: Mutants show reduced novel-arm visitation time and entries compared with controls.
Exp Paradigm: NA
 Y-maze test
 8-10 weeks
Targeted expression1
Decreased
Description: Mutants show no gabrb2 transcript levels in the cerebrum and cerebellum.
Exp Paradigm: NA
 Quantitative pcr (qrt-pcr)
 10-11 weeks
Cns inflammation1
 No change
 Immunohistochemistry
 10-11 weeks
Hippocampal morphology1
 No change
 Immunohistochemistry
 10-11 weeks
Neuronal number1
 No change
 Immunohistochemistry
 10-11 weeks
Circling1
 No change
 Novel cage test
 8-10 weeks
Stereotypy1
 No change
 Novel cage test
 8-10 weeks
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Maternal behavior, Physiological parameters

M_GABRB2_2_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity1
Increased
Description: Mutants show increased locomotor activity in the zil-2 apparatus, compared with controls.
Exp Paradigm: NA
 Novel cage test
 8-10 weeks
Oxidative stress in neurons1
Increased
Description: Mutants show increased levels of malondialdehyde in the brain but no elevation of oxidative markers in the blood or liver.
Exp Paradigm: NA
 Measurement of enzyme activity
 10-11 weeks
Seizures1
Increased
Description: Mutants show increased susceptibility and decreased latency for ptz induced seizures compared with controls. the average latency to seizure was shorter for female than for male.
Exp Paradigm: NA
 Observation of chemically induced seizures
 3 weeks, 10 weeks
Startle response: acoustic stimulus1
Increased
Description: Mutants show increased startle amplitude at 100, 110, and 120 db sounds compared with controls.
Exp Paradigm: NA
 Acoustic startle reflex test
 8-10 weeks
Sensorimotor gating1
Decreased
Description: Mutants show decreased ppi compared with controls at 77110db combinations but not at 83120 db combinations.
Exp Paradigm: NA
 Prepulse inhibition
 8-10 weeks
Social memory1
Decreased
Description: Mutants show decrease in time spent and number of contacts with an unfamiliar mouse over a familiar mouse compared with controls.
Exp Paradigm: NA
 Three-chamber social approach test
 9-10 weeks
Social approach1
Decreased
Description: Mutants show decrease in time spent and number of contacts with an unfamiliar mouse over an empty cup compared with controls.
Exp Paradigm: NA
 Three-chamber social approach test
 9-10 weeks
Depression1
Decreased
Description: Mutants spent less time immobile compared to wildtype controls.
Exp Paradigm: NA
 Tail suspension test
 8-10 weeks
Spatial reference memory1
Decreased
Description: Mutants show reduced target-quadrant visitation time but not entries compared with controls.
Exp Paradigm: NA
 Morris water maze test
 8-10 weeks
Spatial working memory1
Decreased
Description: Mutants show reduced novel-arm entries but not visitation time compared with controls.
Exp Paradigm: NA
 Y-maze test
 8-10 weeks
Targeted expression1
Decreased
Description: Mutants show reduced gabrb2 transcript levels in the cerebrum and cerebellum.
Exp Paradigm: NA
 Quantitative pcr (qrt-pcr)
 10-11 weeks
Anxiety1
 No change
 Elevated plus maze test
 8-10 weeks
Depression1
 No change
 Sucrose preference test
 8-10 weeks
Cytokine levels: pro-inflammatory1
 No change
 Elisa
 10-11 weeks
Reproductive function1
 No change
 Litter size
 8 weeks
Circling1
 No change
 Novel cage test
 8-10 weeks
Stereotypy1
 No change
 Novel cage test
 8-10 weeks
Stereotypy: climbing1
 No change
 Novel cage test
 8-10 weeks
Seizures1
 No change
 Audiogenic seizure test
 3 weeks, 10 weeks
Rearing behavior1
 No change
 Novel cage test
 8-10 weeks
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Maternal behavior, Neuroanatomy / ultrastructure / cytoarchitecture, Physiological parameters

M_GABRB2_3_KO_HT-M-P+

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Depression1
Decreased
Description: Ht-p mutants spent less time immobile compared to wildtype controls.
Exp Paradigm: NA
 Tail suspension test
 8-10 weeks
General locomotor activity1
 No change
 Novel cage test
 8-10 weeks
Stereotypy: climbing1
 No change
 Novel cage test
 8-10 weeks
Rearing behavior1
 No change
 Novel cage test
 8-10 weeks
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Immune response, Learning & memory, Maternal behavior, Molecular profile, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Seizure, Sensory

M_GABRB2_4_KO_HT-M+P-

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity1
Increased
Description: Ht-m mutants show increased locomotor activity in the zil-2 apparatus, compared with controls.
Exp Paradigm: NA
 Novel cage test
 8-10 weeks
Stereotypy: climbing1
Increased
Description: Ht-m mutants show increased climbing compared with controls.
Exp Paradigm: NA
 Novel cage test
 8-10 weeks
Rearing behavior1
Increased
Description: Ht-m mutants show increased rearing compared with controls.
Exp Paradigm: NA
 Novel cage test
 8-10 weeks
Depression1
Decreased
Description: Ht-m mutants spent less time immobile compared to wildtype controls.
Exp Paradigm: NA
 Tail suspension test
 8-10 weeks
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Immune response, Learning & memory, Maternal behavior, Molecular profile, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Seizure, Sensory

 

No Interactions Available
HELP
Copyright © 2017 MindSpec, Inc.